Aignostics
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Alt-moabit 73/73a, Berlin, Berlin, 10555...Website
www.aignostics.comRevenue
$21 MillionIndustry
About Aignostics
Aignostics Org Chart
Is Aignostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aignostics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Aignostics had a recent Job posting/layoffs
Product Launch: Get notified when Aignostics launches new products
Funding: Get notified immidiatlly once Aignostics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Aignostics
Earning: See what the market has to say on Aignostics recently announced quarterly report
Aignostics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Aignostics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Aignostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aignostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aignostics.
Aignostics financials insights
Gather financial insights about Aignostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$14M
Series B
$34M
Aignostics Tech Stack
A closer look at the technologies used by Aignostics
Most Recent Scoops
Aignostics News & Media
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9, 2026 /PRNewswire/ -- Today, Aignostics announced a new...Aignostics Announces New State-of-the-Art Pathology Foundation Model
Atlas 2 sets new industry standard and achieves best-in-class performance and computational efficiency BERLIN and NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Today, Aignostics announced research results for Atlas 2, an updated version of its pathology foundation model. Built in collaboration...Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Atlas H&E-TME delivers robust analyses at single-cell resolution in hours BERLIN and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Following successful early access pilots with leading biopharma partners, Aignostics today announced the general availability of Atlas H&E-TME, an application for...Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Atlas H&E-TME delivers robust analyses at single-cell resolution in hours BERLIN and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Following successful early access pilots with leading biopharma partners, Aignostics today announced the general availability of Atlas H&E-TME, an application for...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aignostics
Aignostics is an international interdisciplinary team focused on powering the next generation of precision medicine and advancing the fields of AI and pathology.... Read More